BALTIMORE, MARYLAND, August 27, 2020 – For Immediate Release –  Flavocure Biotech, Inc. ("Flavocure") a drug discovery and development company, announced today the appointment of David Brooks, M.D., Ph.D. to serve as Interim Chief Medical Officer. Dr. Brooks will be responsibl...